Theralase Technologies Inc (TLTFF)

[123414]

$TLTFF MONTHEY CHART FROM MARCH2019-PRESENT.

The time period shows market confidence collapse and rebuild. After the stellar results from ph1. The company had to change gears. They pushed the clutch in changed gears and are now back on the throttle for the NMIBC NONRESPONSE RACE!!

Who is leading the pack?? Investors in the know go with the strongest!

It's a chart of beautiful symmetry.

With solid science and systematic progress for support.

The support for the company and
for the unmet medical need is very strong.

TLFFF FULL THROTTLE ON THE NMIBC NONRESPONSE.
TLTFF FULL THROTTLE ON CUTTING EDGE COVID RESEARCH.

$TLTFF THE BRIGHTTESTED LIGHT ON THE DARKEST NIGHT!

TLTFF Millions in the back and a tiny tiny tiny burnrate.

The SESN COMPETITOR FDA BACKBURNER WAS THE BURNER.
.37 TO SEX BUCKS. SESN WAS NOT THE STRONGEST.
SESN - got hit by the backburner. All those safety violations...
Go sit in the corner you bad boy!

TLTFF 67% CR @ 18 MONTHS PHASE1 FROM ONE TREATMENT
With patients released from the study at 18 months.
Only the doctor and the patient know the 24 month results.

But then the PI set the dosage back for the PH2 PIVITOL
at about a 70 percent dose for some of the for some of the first 12 patients treated in PH2 PIVITOL. Ph2 PIVITOL HAS TWO TREATMENTS. lol

What's up Doc?? Maybe you were concerned for overtreating patients and gave them the full dose on the next 6 month treatment as a mop up?

$TLTFF The market is aware of you!!